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doi:10.1016/j.jtcvs.2008.02.068Objective: External mesh support of vein grafts has been shown to mitigate the for-
mation of intimal hyperplasia. The aim of the present study was to address the issue
of optimal mesh size in a nonhuman primate model that mimics the dimensional mis-
match typically encountered between clinical vein grafts and their target arteries.
Methods: The effect of mesh size on intimal hyperplasia and endothelial preservation
was assessed in bilateral femoral interposition grafts in Chacma baboons (nS 5 32/n
5 8 per mesh size). No mesh support (group I) was compared with external nitinol
meshes at three different sizes: loose fitting (group II), 25% diameter constricting
(group III), and 50% diameter constricting (group IV). Mesh sizes were seen not
only in isolation but also against the background of anastomotic size mismatch at im-
plantation, expressed as quotient of cross-sectional area of host artery to vein graft
(QC).
Results: Significant amounts of intimal hyperplasia were found in group I (QC median
0.20; intimal hyperplasia 6 weeks5 1.636 0.34 mm2; intimal hyperplasia 12 weeks
5 1.73 6 0.5 mm2) and group II (QC median 0.25; intimal hyperplasia 6 weeks 5
1.96 6 1.64 mm2; intimal hyperplasia 12 weeks 5 2.88 6 1.69 mm2). In contrast,
group III (QC median 0.45; intimal hyperplasia 6 weeks5 0.086 0.13 mm
2; intimal
hyperplasia 12 weeks 5 0.18 6 0.32 mm2) and IV (QC median 1.16; intimal hyper-
plasia 6 weeks 5 0.02 6 0.03 mm2; intimal hyperplasia 12 weeks 5 0.11 6 0.10
mm2) showed dramatically suppressed intimal hyperplasia (P , .01) at both time
points. Endothelial integrity was only preserved in group IV (P , .05). There were
no significant differences in vascularization and inflammation in either interlayer or
intergroup comparisons.
Conclusion: By using an animal model that addressed the clinical phenomenon of di-
ameter discrepancy between vein graft and bypassed artery, we could demonstrate
that suppression of intimal hyperplasia required constrictive mesh sizes.
W
hen used as arterial bypass grafts, veins have a distinctly lower patency rate
than arteries.1 The main pathologic processes behind failing vein grafts are
intimal hyperplasia2 and atherosclerotic degeneration.3 Inasmuch as inti-
mal proliferation typically precedes atherosclerotic degeneration4 it can also be
seen as the ‘‘soil’’ for atherosclerotic vein graft changes.5 Therefore, subintimal tissue
formation ultimately holds the key to the disappointing performance of vein grafts. A
clinical consequence of the unsatisfactory patency rate of vein grafts was an increas-
ing use of arterial grafts. Despite this trend, however, vein grafts remain the most
widely used bypass conduits. Therefore, improving the patency of vein grafts is still
a highly desirable goal. Understanding what causes the formation of vein graft intimal
hyperplasia holds a key toward this goal.
Among the many factors contributing to the development of flow-limiting intimal
hyperplasia, two are of central importance: low shear stress at the endothelial/blood
interface6 and high circumferential wall stress.7 In a defined system, Pouiseille’s
law stipulates that circumferential stress increases and shear stress decreases withThe Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 3 717
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ANOVA 5 analysis of variance
BFV 5 baboon femoral vein
BSV 5 baboon lesser saphenous vein
ID 5 inner diameter
OD 5 outer diameter
QC 5 quotient of cross-sectional area of host artery
to vein graft
increasing diameter. Therefore, the relatively large diameter
of clinically available vein grafts as compared with their tar-
get arteries–especially as seen in coronary surgery–is in itself
a trigger for subintimal tissue proliferation.6,7 Additional di-
latation of vein grafts after implantation further aggravates
the situation. Vice versa, diameter reduction together with
a decrease in wall tension can be expected to have an inhib-
itory effect on the formation of intimal hyperplasia.
As early as in 1963, Parsonnnet, Lari, and Shah8 proposed
the concept of external mesh support with the goal of con-
stricting the vein graft diameter to that of the artery, as well
as preventing dilatation. Since then, the principle of vein graft
protectionwith externalmeshes has been repeatedly revisited,
but the multitude of animal models, materials, and diameters
used resulted in opposing recommendations.9-11 To clarify
a situation that has a significant potential to improve the clin-
ical outcome of bypass surgery, we adopted a nonhuman pri-
mate model that mimicked the diameter mismatch of vein
grafts and host arteries of patients. By comparing mesh sizes
that created a spectrum, from loose fitting to a 50% diameter
reduction, we attempted to determine an optimal size for vein
grafts. Furthermore, by using the hyperelastic shape-memory
material nitinol for the first time, we added amechanical resil-
ience factor that had not been addressed in the past.
Materials and Methods
Study Design
A bilateral femoral interposition model was first established in non-
human primates that attempted to mimic the anastomotic size mis-
match of clinical vein grafts.
Subsequently, non–mesh-supported controls were compared
with 3 groups of meshes: loosely size matched (6.7 mm; n 5 8),
moderately constrictive (25% diameter reducing; 5.0 mm; n 5
8), and distinctly constrictive (50% diameter reducing; 3.3 mm;
n5 8). Grafts were analyzed after 6 and 12 weeks of arterial implan-
tation.
The incremental approach of first pairing nonsupported control
grafts with 5.0-mm mesh-supported grafts in one set of animals fol-
lowed by pairing of 3.3-mm meshes with 6.7-mm meshes in a sub-
sequent set, followed by comparison across all 4 groups, was
justified by 1-way analysis of variance (ANOVA) testing of in
situ (preharvest) quotients of cross-sectional areas (Qc) of vein
grafts to target arteries that confirmed a priori homogeneity of var-
iance.718 The Journal of Thoracic and Cardiovascular Surgery c SepVein Source Comparison
Chacma baboons do not have an equivalent to the human greater sa-
phenous vein (‘‘magna’’) but do have one corresponding with the
lesser saphenous vein (‘‘parva’’). To determine the relevance of
available baboon veins in the context of human saphenous vein
grafts, histologic architecture and dimensions of human greater sa-
phenous veins of 7 prospectively chosen patients were compared
with those of the lesser saphenous veins (BSVs) and superficial fem-
oral veins (BFVs) of 7 baboons (30.56 4.3 kg) unrelated to the im-
plant group. The effect of wall compression against an external mesh
was assessed by pressure fixation (120 mm Hg) inside 3.3-mm
nitinol meshes.
External Nitinol Meshes
Nitinol wires (BB Ni-Ti alloy: nickel 56.0 wt%, titanium 43.9365
wt%, carbon 0.033 wt%, oxygen 0.028 wt%, hydrogen 0.0025
wt%; thickness: 25/50 mm; Fort Wayne Metals, Fort Wayne, Ind)
were braided using a 48-carrier braiding machine (Medtronic Vas-
cular, Danvers, Mass [3.3 mm and 6.7 mm/50 mm] and a 72-carrier
braiding machine (Prodesco Secant Medical, Perkasie, Pa [5.0 mm/
25 mm]). Comparable wire density was achieved in all 3 diameters
by choosing 24, 36, and 48 wires per circumference for the 3.3-
mm, 5.0-mm, and 6.7-mm braid. The braid angle and pitch were
125 and 0.304 mm, respectively. Compliance was measured by cir-
cumferential tensile testing (Instron 5544 [Instron, Norwood,Mass],
distilled water, 37C). All 3 mesh diameters had a negligible com-
pliance at 120/80 mm Hg of 1.14% 6 0.065%/100 mm Hg (3.3
mm), 2.06% 6 0.04%/100 mm Hg (5.0 mm), and 2.19% 6
0.12%/100 mm Hg (6.7 mm). The mesh diameters at 120/80 mm
Hg filling pressures were calculated from the nonpressurized diam-
eters (0 mm Hg) and the radial compliance of each mesh size, as-
suming a linear increase in diameter with an increase in pressure.
The inner diameters of the meshes at 120/80 mm Hg were 3.39/
3.37 mm (3.3-mm meshes), 5.12/5.08 mm (5.0-mm meshes), and
6.86/6.80mm (6.7-mmmeshes).Mesh dilatation at explantationwas
determined on the basis of cross-sectional image analysis of resin-
embedded, pressure-fixed midgraft cross sections (Nikon E 1000
0.53macro-lens/Leica QWin ProV2.5; Nikon, Tokyo, Japan; Leica
Microsystems, Wetzlar, Germany) pressure-fixed at 120 mm Hg.
Experimental Surgery
Adult chacma baboons (n5 16; 18.16 0.9 kg) were provided by the
breeding and quarantine facilities of the South African Medical Re-
search Council. All experiments were approved by the Health Sci-
ences Faculty Animal Ethics Committee of the University of Cape
Town. Surgery and preoperative and postoperative care complied
with the ‘‘Principles of Laboratory Animal Care’’ and the ‘‘Guide
for the Care and Use of Laboratory Animals’’ (NIH publication No.
86-23). Under general anesthesia, reversed superficial femoral
veins—taken between the adductor canal and the confluence with
the deep femoral vein—were used as bilateral femorofemoral interpo-
sition grafts. In the mesh-supported groups, the veins had been gently
pulled through an introduction tube inside the mesh before grafting.
Macroscopic Graft Dimensions
At implantation, measurements were taken with a caliper in the mid-
dle of the segment assigned for excision or after interposition graft-
ing using a ‘‘no-touch’’ technique. Arteries and grafts weretember 2008
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sectional areas (QC 5 ah/ag whereby ah represents the cross-sec-
tional area of the host vessel and ag that of the interposition graft)
was chosen to express the dimensional mismatch between vein graft
and host artery and indirectly as a reflection of flow velocity.
At explantation, grafts were perfusion-fixed (10% formalin/120
mmHg) before they were resected en bloc. Midgraft sections under-
went macroscopic image analysis for luminal dimensions (QWinPro
V2.5; Leica Microsystems Imaging Solutions).
Light Microscopy
Two series of 25 consecutive sections (3 mm; nitinol wires removed)
were cut for paraffin histology. The series were approximately 300
mm apart and used for light microscopy (modified Movat’s, elastic
Masson’s trichrome, and picrosirius red for diascopic polarization
microscopy of collagen/Nikon E1000M and a Nikon Coolscope)
and immunofluorescence (CD31; FVIII:rAg; Actin/Desmin; CD
68; Antibody8740/MAC387 and Ki-67 with a nuclear Dapi counter-
stain/Nikon 90i). Non-dewired midgraft sections were infiltrated
with Technovit T8100 resin (Heraeus-Kulzer, Wehrheim, Germany)
and cut with an Isomet Precision Saw (Buehler, Dusseldorf, Ger-
many) before being stained with hematoxylin and eosin.12
Electron Microscopy
After perfusion fixation in formalin, samples for electron micros-
copy were postfixed in 2% glutaraldehyde in phosphate-buffered
saline solution. After processing, scanning electron microscopy
images were digitally captured by Orion V5.20 software (Eli, Char-
tleroi, Belgium) before undergoing image analysis. Transmission
electron microscopy sections were viewed with a Philips TEM420
(Carl Zeiss, Veldhoven, The Netherlands) and images captured on
a SIS Megaview III CCD camera (Olympus Soft Imaging Solutions
GmbH, Mu¨nster Germany).
Microscopic Assessment
For image analyses, composite images were assembled from digital
single frames captured at 43 or 103 magnification (Nikon Eclip-
se90i and Nikon Coolscope) using EclipseNet (Laboratory Imag-
ing, Prague, Czech Republic) software. Light/polarized light
toggle analyses between combined modified Masson’s trichrome
and picrosirius stains were used for image analysis of wall thick-
ness and dimensions of wall layers. Intimal hyperplasia tissue
was discernible both by its demarcation through a clear though
sometimes fragmented internal elastic lamella and its distinctly
weaker staining for actin and desmin than the adjacent media.
The adventitial layer was defined between the outer demarcation
of the media and the inner demarcation of the dense circumferen-
tial collagen structures characterizing the fibrous capsule. Precise
mesh positions were determined on resin sections. Assessment of
media muscularity, vasa vasorum, nuclear density, inflammatory
cell infiltration, and cell proliferation, as well as verification of sur-
face endothelialization, was based on immunofluorescence com-
posite pictures. Entire wall layers were analyzed. Cellularity was
related to the cross-sectional area of wall layers. Muscularity was
defined as the partial cross-sectional area of smooth muscle cells
within the boundaries of the media. Cellular phenomena such as
cell proliferation (Ki67) and macrophage infiltration were related
to the cellularity (Dapi positive nuclei per area) of each layer.The Journal of ThoVasa vasora (number of vessels; partial cross-sectional area)
were related to cross-sectional areas of wall layers (Figure 1).
For the assessment of surface endothelialization, the presence of
endothelial cells on the blood surface was first immunohistochemi-
cally confirmed (CD31) before image analysis (Scion Image soft-
ware; National Institutes of Health, Bethesda Md) of scanning
electron micrographs was used for quantification.
Statistical Analysis
All statistical analyses were performed with the JMP6.0.2 (SAS,
Inc, Cary, NC) application on an Apple PowerPC-based Macintosh
computer (Apple, Cupertino, Calif). All continuous numerical vari-
ables were expressed as means6 sample standard deviation, unless
otherwise stated.
For assessment of the differences between vein types, 1-way
ANOVA of layer dimensions was followed by Tukey-Kramer hon-
estly significant difference post hoc analysis.
Analysis of change in cross-sectional luminal areas excluded
preimplant values from inferential analyses of the remaining time
points since these referred to unrestricted in situ veins.
Comparison of layer dimensions before and after external mesh
support was performed by the Student t test with 1-tailed P values
being reported. Nonparametric testing using the Wilcoxon rank
sum test was used for comparison of QC data between groups. AN-
OVA testing was used for the analysis of the 3 time points (implant,
6 weeks, and 12 weeks) with the Dunnet t test being used for post
hoc analysis of values at 6 and 12 weeks versus implant control
values. Similarly, cross-sectional anatomic layer areas were exam-
ined by ANOVA testing with post hoc between-group comparisons
using the Student t test with Bonferonni correction of 2-tailed P
values for multiple comparisons. Square root transformation of inti-
mal hyperplasia area data was performed following the Shapiro–
Wilk testing for normality. Patency of grafts was examined using
Fisher’s exact test.
Results
Validation of Vein Source
Arterially distended BSVs were almost size matched with the
superficial femoral arteries (QC 5 0.89 6 0.31), whereas
BFVs were distinctly larger (QC5 0.226 0.04). The differ-
ence in QC was highly significant (P, .0001, Student t test).
The overall wall thickness of BFVs (576.9 6 174.3 mm
unsupported/393.9 6 174.3 mm mesh supported) was com-
parable with that of human greater saphenous veinss (562.6
6 231.2 unsupported/436.7 6 137.4 mm mesh supported)
whereas that of the BSVs (317.0 6 59.3 mm unsupported/
206.7 6 55.4 mm mesh supported) was significantly less
(P 5 .028/P 5 .009).
The histologic comparison of vessel wall layers showed
the media of both baboon veins to be of similar composition
and only mildly thinner than that of the human greater saphe-
nous vein (23% BSV; P 5 not significant; 24% BFV; P 5
not significant). Furthermore, muscular contraction seemed
to enable smooth caliber adjustment of the veins. None of
the veins inside nitinol meshes of half the maximal vein graft
diameter showed signs of folding or buckling.racic and Cardiovascular Surgery c Volume 136, Number 3 719
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Dimension, and Cross-sectional Quotient of Vein
Grafts
Graft patency was 87.5% at 6 weeks and 75.0% at 12 weeks
with no significant difference between the time points and/or
the groups.
On exposure to the arterial circulation, vein grafts of the
unsupported control group expanded by 24% outer diameter
(OD) (P5 .09). After a similar distention within the 6.7 mm
meshes, the OD of vein grafts and the inner diameter (ID) of
meshes were almost size matched (ODVein graft 3.6% 6
13.3% , IDMesh). In contrast, the 5.0-mm and 3.3-mm
meshes led to a diameter reduction of vein grafts by 25.9%
6 12.3% and 48.7% 6 6.6%, respectively. As a result, the
QC differed significantly (P , .0001; Wilcoxon rank sum
test) between the control group (QC median 5 0.20; range
0.18–0.42) and the 6.7-mm meshes (QC median 5 0.25;
range 0.23–0.47) on the one hand and 5.0-mm (QC median
5 0.45; range 0.43–0.47) and 3.3-mm meshes (QC median
5 1.16; range 1.13–1.18) on the other. After 6 weeks of im-
plantation, control veins experienced a 63% cross-sectional
narrowing of the lumen (P, .05) (Figures 2 and 3), followed
by a distinct 188% dilatation at 12 weeks (P5 .027; Dunnet t
Figure 1. Image analysis of cross sections of pressure-fixed, ex-
planted grafts by (a) manual delineation and quantification of an-
atomic zones on tiled stitched elastin-Masson trichrome images
followed by (b) quantification of vasa vasorum within these zones
on tiled factor VIII immunofluorescence images. The entire high-
resolution image, a section of which is shown in (c), was trans-
lated into vessel area data for each zone after hue saturation
and intensity detection (d). IH, Intimal hyperplasia tissue.720 The Journal of Thoracic and Cardiovascular Surgery c Septest) (Figures 2 and 3). Although the meshes prevented such
an extreme vein graft dilatation, some degree of mesh dilata-
tion was also observed (Figure 3).
Vessel Wall Dynamics
Macroscopic cross-sections of 6-week explants showed dis-
tinctly thickened, whitish vessel walls in both the control
group and the 6.7-mmmesh-supported group (Figure 4), cor-
responding histologically with a dramatic increase in wall
thickness (127%, P , .0001 in controls; 342%, P , .0001
in 6.7-mm meshs) (Figures 5 and 6). As much as intimal pro-
liferation was pronounced (Figure 6), it only accounted
for17.4% 6 6.4% (unsupported) and 14.3% 6 7.9% (6.7-
mmmesh supported) of the overall increase in wall thickness.
The bulk of tissue formation took place in the fibrous capsule
that ‘‘filled’’ the more than 0.5-mm wide space between the
mesh and the adventitia. In contrast, a relatively thin vessel
wall was regularly found in the 2 mesh-supported groups
that constricted the vein grafts. At 12 weeks, cross-sectional
appearances remained unchanged, but histologically there
was a general decrease in medial and adventitia thickness.
Endothelium
At 6 weeks, the endothelium was patchy to largely absent in
controls aswell as the 6.7-mmand the 5.0-mmmesh-supported
groups, with no significant difference between the groups. At
12weeks, these groups showed only amild trend toward re-en-
dothelialization (from33.3% to 43.5% in controls, from29.3%
to 34.5% in 6.7-mm meshes, and from 29.3% to 55.3% in
5.0-mm meshs; no significant difference). In contrast, vein
Figure 2. Change in cross-sectional luminal area. Preimplant
values reflect the luminal area of in situ BSVs and were excluded
from inferential statistical analysis of the remaining time points.
Non–mesh-supported control grafts underwent a significant nar-
rowing of the lumen during the initial 6 weeks followed by
a marked dilatation thereafter. The mild trend toward luminal
enlargement in the mesh-supported grafts is a reflection of
mesh dilatation.tember 2008
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Figure 3. Non-dewired midgraft sections representing all 8
groups. (Resin; precision sawed and ground; hematoxylin and
eosin stain, 0.53lense) The circles inserted in the control group
highlight the degree of shrinkage during the initial 6 weeks and
the extent of dilatation thereafter. In the 6.7-mm mesh-supported
group and to a mild degree in the 5.0-mm group, the gap between
the shrunken vein grafts and the mesh is filled with fibrous tissue.
Note the delicate thin wall of veins inside the 50% diameter-con-
strictive 3.3-mm meshes. There is a shallow longitudinal fold in
the 12-week section. Numbers inserted in the left upper corner
represent the percentage diameter dilatation of the meshes
when compared with their dimensions at implantation. N.S., Not
significant.The Journal of Thografts supported by 3.3-mmmeshes showed a confluent endo-
thelium differing significantly in percentage coverage (100%)
from all other groups (P5 .05). At 12 weeks the endothelium
in the 3.3-mm mesh-supported group was still largely conflu-
ent (91.7%; no significant difference).Ultrastructurally, the en-
dothelium of mesh-supported grafts occasionally showed
a mild ripple-mattress appearance with circumferential micro-
folds, a phenomenon particularly pronounced in the 3.3-mm
group. Overall, no thrombotic surface appositions were found
even on endothelium-denuded surfaces.
Intima
Two typical pictures prevailed throughout: a distinct, irregu-
lar, and often half moon–shaped intimal tissue that was rich
in extracellular matrix in both the control group and the
6.7 mm meshes as opposed to a near complete absence of
Figure 4. Macroscopic comparison of 6-week vein grafts sup-
ported by 6.7-mm meshes (left; a and c) and 3.3-mm meshes (right;
b and d). In the 6.7-mm mesh-supported group, there is clear dis-
tinction between the more whitish vessel wall and the fibrous tis-
sue filling the gap between vessel wall and mesh. Note the
delicate vessel wall inside the 3.3-mm mesh.racic and Cardiovascular Surgery c Volume 136, Number 3 721
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diameter constrictive 3.3-mm mesh support g–i) stained with modified elastic Masson's trichrome (left and middle
column) and modified Movat's (right column). Small rectangles indicate high magnification areas shown in middle
column (203 objective); larger rectangles represent areas shown in right column (103 objective). Pronounced, ex-
centric glucosaminoglycans-rich (blue) intimal hyperplasia with discernible internal elastic lamella ([) and loose
collagen-rich media in controls and the size-matched group. Distinct (50%) downsizing abolished intimal hyperpla-
sia tissue (IH) and led to a thin, compacted media.722 The Journal of Thoracic and Cardiovascular Surgery c September 2008
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mm groups. An internal elastic membrane was regularly pres-
ent (Figure 5). The most dramatic increase in intimal tissue
occurred in the 6.7 mm mesh-supported group, where it con-
tinued beyond the initial 6 weeks of implantation (Figure 6).
In nonsupported controls, intimal hyperplasia appeared to
reach a cross-sectional equilibrium at 6 weeks, leading to
a relative thinning of the neointima at 12 weeks, correspond-
ing with graft dilatation.
Media
The doubling of medial thickness in controls and the 6.7-mm
mesh-supported group during the initial 6 weeks was associ-
ated with an actual drop inmuscularity from 60.9%6 13.0%
(at implant) to 33.3% 6 3.3% (controls; P 5 .0046) and
35.9% 6 3.8% (6.7-mm meshes; P 5 .0226). Overall, a di-
minished total amount of smooth muscle tissue was found
within the media (237.8%, P 5 .0015 in controls;
241.9%, P 5 not significant in 6.7-mm meshes; 281.2%,
P , .0001 in 5.0-mm meshes, and 293.6%, P , .0001 in
3.3-mm meshes). Intimal cells showed signs of high secre-
tory activity on transmission electron microscopy. Remnants
of platelets were found within the extracellular matrix.
Adventitia, Fibrous Capsule, and Periadventitia
The two most striking features of these outer layers were the
almost absent inflammatory response against the nitinol
struts (except for a few foreign body giant cells) and the sur-
prising abundance of elastin in the mesh-supported groups
(between the mesh and the media as well as relatively far out-
side the mesh in the periadventitial layer). The fibrous
capsule was distinctly thicker in 6.7-mmmeshes than in other
vein grafts after 6 weeks (280% vs controls, P 5 .0052;
198% vs 5.0-mm meshes, P 5 .0308; and 270% vs
Figure 6. Cross-sectional area of intimal hyperplasia tissue. The
bulk of proliferation occurs during the initial 6 weeks.The Journal of Thor3.3-mm meshes, P5 .0089), while no further change in cap-
sule thickness was observed in any of the groups thereafter.
Inflammatory Response
The 6-week macrophage index of the intimal tissue was
higher in the 6.7-mm group than in any other group but fol-
lowed the overall trend of an abating macrophage response at
12 weeks. No significant differences were found between the
groups.
Cell Proliferation
The ratio of proliferating to resting surface endothelial cells
was below 1.2% in all groups except in the 6.7-mm mesh-
supported group, where it was 14.4% (6 weeks) and 2.4%
(12 weeks) (no significant difference). Within the wall layers,
the proliferative activity did not exceed 3% at any time point.
The only significantly higher proliferation index in interlayer
and intergroup comparisons was found in the fibrous capsule
of the 6.7-mmmesh-supported group at 6 weeks (P5 .0018).
Vascularization
In the 3.3-mm and 5.0-mm groups, the ingrowth of vasa
vasorum was confined to layers outside the media, whereas
the controls and the 6.7-mm groups showed scanty vessels
also within the media and neointima, at both 6 and 12 weeks.
Inasmuch as vessel density and cross-sectional area increased
over time, this trend, as well as intergroup and interlayer
comparisons, were not significant.
Discussion
Our present study confirmed, in a nonhuman primate model,
that the benefit of external mesh support of vein grafts is
closely linked to a concomitant reduction of the size mis-
match between vein grafts and host arteries.
The main underlying paradigm of the study was that the
basic biomechanical principles that regulate intimal hyper-
plasia in general also determine the effect of external meshes.
Given the fact that low shear stress and high circumferential
wall stress are prime switches for the development of intimal
hyperplasia6 Pouiseille’s law implies that the diameter mis-
match usually encountered between a large vein graft and
a small host artery is a main trigger for the development of
intimal hyperplasia. Inversely, it also implies that constrictive
mesh sizes should counter this trigger and thus exert a sup-
pressive effect on intimal hyperplasia.
By using the relatively small saphenous veins for interpo-
sition grafts in large arteries such as the carotids, some of the
previous studies created experimental flow conditions that
were distinctly different from the clinical situation. There-
fore, conclusions regarding the effectiveness of loose-fitting
meshes11, 13-15 are not unconditionally applicable to human
bypass surgery.
In coronary artery bypass surgery, for instance, reversed
saphenous veins are most often used for grafting of theacic and Cardiovascular Surgery c Volume 136, Number 3 723
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descending artery.
Given the average dimension of these coronary arteries
(midsection ID/cross-sectional area 2.1 mm/3.4 mm2 and
1.8 mm/2.5 mm2, respectively16), as well as that of saphe-
nous vein grafts (OD 4.18 6 0.4 mm; wall thickness 458
6 17 mm; cross-sectional area 8.4 mm2; 200 consecutive pa-
tients; unpublished data), the quotients of cross-sectional
areas (QC) would be in the region of 0.30 to 0.40. Under clin-
ical circumstances, where the runoff may be compromised,
the QCmay even be below 0.30. In contrast, if an internal tho-
racic artery (average OD: 3.01 6 0.51 mm; wall thickness
2486 108 mm; cross-sectional area 6.06 0.46 mm2; unpub-
lished data) was used to graft the midsection of the left ante-
rior descending artery (ID 2.6 mm; cross-sectional area 5.3
mm2 16), the cross-sectional quotient would be 0.88.
In our present study, the QCs for control grafts and size-
matched mesh-supported grafts were therefore similar to
the QCs estimated for clinical vein grafts. Hence, it was not
surprising that both the control and size-matched groups
showed a degree of diffuse early intimal hyperplasia typi-
cally found in the majority of coronary bypass grafts of
patients.17 In contrast, when the QC was increased to more
than 0.45 through diameter reduction of the vein graft, inti-
mal hyperplasia was almost completely suppressed. This
interdependent consideration of graft constriction and pre-
existing diameter mismatch between vein graft and host ar-
tery may resolve the puzzle as to why some studies reported
distinctly better results with constricting meshes9,10,18-21
while others saw a positive effect with lose-fitting
meshes.11,13-15 Typically, those promoting constrictive
mesh sizes used relatively large venous conduits with an es-
timated QC of between 0.15 and 0.4,
9,10,18-21 whereas those
seeing a benefit in oversizing used smaller vein grafts with
an estimated QC of up to 0.7.
11,13-15 It is therefore evident
that those studies advocating the oversizing of external
meshes used animal models in which the vein grafts were rel-
atively narrow when related to the runoff vessels and thus
experienced higher a priori shear forces at the endothe-
lium–blood interface. It has been shown that the threshold
value for local levels of wall shear stress is 5 dynes/cm2 be-
low which intimal thickening occurs.22 With a QC of as high
as 0.7, this threshold is not even remotely undercut, even if
grafts remain unsupported. Therefore, constrictive mesh
sizes would not have added an additional shear-stress benefit
under these circumstances. The fact that differences were still
seen between mesh-supported and unsupported grafts despite
the high baseline QC may be explained with a ‘‘tamponad-
ing’’ effect inside the mainly used Dacron grafts caused by
the known seroma buildup between graft and vein.23
Thereby, even oversized meshes would turn into expan-
sion-limiting devices. The resulting lower tangential wall
stress would show an effect even if the shear forces remained
subthreshold throughout.724 The Journal of Thoracic and Cardiovascular Surgery c SepAlternatively, different degrees of wall vascularization
and/or inflammation were suggested as explanations for the
protective effect of external vein support. A high vasa vaso-
rum density was seen as a key mechanism through which
loose-fitting Dacron meshes suppressed the development of
intimal hyperplasia. In return, the ineffectiveness of tight-sit-
ting Dacron meshes was explained by a lack of vasa vasora.15
The near absence of a microvessel plexus inside such meshes
was ascribed to insufficient space for the development of
a neoadventitia between mesh and vein graft.23 Since the del-
icate and wide-open nitinol meshes, which we used for exter-
nal support, allowed for a well-developed vasa vasorum
plexus in the neoadventitia of all groups, the previously re-
ported effect of constrictive meshes on vasa vasorum forma-
tion may well be specific for polymeric fabrics. The fact that
we observed a near-complete suppression of intimal hyper-
plasia suggests that vasa vasora cannot be seen as exclusive
mechanisms behind the effect of external vein meshes. Sim-
ilarly, the level of inflammation seen in our nitinol mesh–sup-
ported grafts was distinctly lower than that described for
synthetic24 or resorbable meshes of previous studies.11 The
distinct inflammatory response to Dacron was offered as
one explanation for the failure of tight-sitting meshes.
However, as much as the suppression of intimal tissue pro-
liferation is crucial in vein grafts, one must not overlook the
importance of endothelial preservation. In our present study,
endothelial preservation was even more affected by mesh
size than intimal hyperplasia. While a 25% diameter reduction
was sufficient to largely suppress intimal hyperplasia, this
moderate diameter reduction led to a similar degree of early
endothelial cell detachment as in control veins and the size-
matched mesh-supported group. In contrast, 50% diameter
constrictions to QCs above 1.10 appeared to completely pre-
serve the endothelium. This apparent correlation of a high
QC with endothelial preservation seems to be in accordance
with most previous studies: the most pronounced difference
in endothelial integrity between mesh-supported grafts and
unsupported controls was found in those studies in which
the baseline QC seemed low
9,20,25 and mesh support resulted
in a significant constriction of the vein grafts. In contrast,
when the baseline QC was already high, no significant endo-
thelial loss was observed whether vein grafts were mesh sup-
ported or unsupported.14 This confirms a previously suggested
link between low shear stress and endothelial detachment.26,27
It could explain why, in the present study, all 3 groups with
shear forces below or equal to 5 dynes/cm2 showed substantial
endothelial loss as opposed to the near complete endothelial
preservation in the 50% diameter–constricted group, where
the estimated wall shear stress was higher than 20 dynes/cm2.
Apart from intimal hyperplasia and endothelial preserva-
tion, another observationof thepresent studywas adiminishing
overall quantity of smoothmuscle cells in themedia. This atro-
phy of vascular muscle tissue puts a process often described as
‘‘arterialization’’ of vein grafts into perspective. Hence,tember 2008
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ETincreases inmedial thicknessmayhavebeenmerelya reflection
of a combination of bulk compression resulting from adventi-
tial shrinkage and pronounced extracellular matrix deposition.
Given the fact that veins reach their adventitial ‘‘arrest’’ point at
as low a pressure as 30 mm Hg, loss of pulsatility may be one
reason for this medial atrophy. This explanation would be sup-
ported by the even more dramatic net reduction in medial
smooth muscle cells found in constrictive meshes where the
noncompliant mesh absorbed the wall strain even more than
the adventitial collagen in unsupported grafts.
In summary, we could demonstrate in a nonhuman pri-
mate model that moderately constrictive external vein
meshes made of the hyperelastic shape-memory material ni-
tinol are capable of almost completely abolishing the forma-
tion of intimal hyperplasia. If the goal of vein graft protection
is also to preserve endothelial integrity, an even higher degree
of diameter reduction seems to be required that mimics the
cross-sectional area quotient between internal thoracic artery
grafts and the left anterior descending coronary artery.
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